Serum levels of ALCAM have shown promise as a prognostic indicator in prostate cancer, while increased tissue levels of ALCAM have been associated with a more aggressive cellular phenotype and metastasis 28. The gene discussed is ALCAM; the disease is prostate carcinoma.